Clinical trial
Molecular and Clinical Study of the Effect of Zaxcell Versus Effezel in the Inflammatory and Scarring Process of Moderate and Severe Acne
NCT03076320 is registered in ClinicalTrials.gov with University of Guadalajara as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular and Clinical Study of the Effect of Zaxcell Versus Effezel in the Inflammatory and Scarring Process of Moderate and Severe Acne
- Lead sponsor
- University of Guadalajara
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 27, 2017
- Completion date
- March 31, 2019
- Enrollment
- 82 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acne vulgaris superficial mixed comedonal and inflammatory